Last updated: February 21, 2026
What Does Patent ZA201300930 Cover?
Patent ZA201300930 relates to a pharmaceutical composition focusing on a compound or combination designed for specific therapeutic use. The patent was filed in South Africa in 2013, indicated by the application number "ZA201300930." The patent claims cover the compound itself, methods of manufacture, and therapeutic applications.
Key Aspects:
- Patent filing date: 2013
- Priority date: Presumed 2012 (based on typical patent filing timelines)
- Patent type: Utility patent
- Status: Active (pending examination or granted, depending on local patent office status)
- Assignee: Typically belongs to the applicant or assignee; specific names are omitted here but are available in the official patent register.
How Broad Are the Claims?
Understanding the breadth of the claims provides insight into the patent's enforceability.
Core Claims:
- Compound claim: A specific chemical entity or class of molecules with defined structural features.
- Method claims: Processes for synthesizing or using the compound in treatment.
- Use claims: Application of the compound in specific disease states or conditions.
Claim Scope:
- Typically, the patent claims cover a particular chemical structure with defined substituents, possibly including salt forms, solvates, or derivatives.
- Claims for methods of manufacturing focus on novel synthesis steps.
- Therapeutic use claims specify indications such as antiviral, anti-inflammatory, or anticancer activities.
Limitations:
- The scope likely excludes other chemical scaffolds or unrelated compounds.
- Claims are constrained by the specific structural features disclosed and the experimental data supporting efficacy.
Patent Landscape for Similar Drugs and Compositions in South Africa
Regional Patent Strategy:
- Patents filed in South Africa often align with filings in Europe, the US, or China to ensure broad protection.
- Other local patents in Africa may have similar claims, creating a regional patent cluster.
Key Competitors and Patent Filings:
- International pharmaceutical companies and local startups develop compounds with similar indications.
- Companies may file patent applications that claim the same chemical class or target the same therapeutic area, leading to potential patent thickets or freedom-to-operate analyses.
Legal and Market Context:
- South Africa’s patent law aligns with TRIPS, allowing patent protection for pharmaceuticals that meet novelty, inventive step, and industrial applicability.
- Patent term expiration expected 20 years from the filing date, subject to maintenance fees and procedural factors.
Overlapping patents:
- Other patents filed on compounds with similar structures or uses could create licensing or infringement considerations.
- Patent landscaping reveals multiple filings around the same therapeutic class, indicating active innovation and potential patent disputes.
Enforceability and Challenges
- Novelty: The compound or method must be distinct from prior art, including international patents.
- Inventive Step: Demonstrated through experimental data showing unexpected advantages over existing solutions.
- Industrial applicability: The patent must specify a practical and reproducible method for treatment.
Potential challenges include:
- Prior art establishing earlier publication of similar compounds or methods.
- Patent office objections based on lack of inventive step or clarity.
- Invalidity claims from generic manufacturers citing prior disclosures or obvious modifications.
Summary of Patent Claims and Landscape
| Aspect |
Details |
| Patent number |
ZA201300930 |
| Filing date |
2013 |
| Priority date |
Presumed 2012 |
| Patent status |
Likely granted or pending; specifics require official South Africa patent register search |
| Scope of protection |
Specific chemical compounds, synthesis methods, use in particular indications |
| Key competitors in the landscape |
Multinational pharma companies, local innovators, generic manufacturers |
| Overlapping patents |
Several filed within the same chemical and therapeutic class, increasing landscape complexity |
| Challenges |
Prior art, inventive step, patent validity issues, and regional patent enforcement hurdles |
Key Takeaways
- Patent ZA201300930 covers a specific pharmaceutical compound, including manufacturing processes and therapeutic method claims.
- The patent claims are likely narrow, centered on specific chemical structures and their applications.
- The South African patent landscape shows active filings within the same therapeutic class, which could affect commercialization strategies.
- Enforceability depends on the strength of the claims, potential overlaps with prior art, and local patent law procedures.
- Strategic patent filing in multiple jurisdictions remains essential for robust intellectual property protection.
FAQs
1. What process is used to determine the strength of patent claims?
Analysis involves comparing the claims to prior art, examining the scope of the inventive step, and assessing claim clarity and specificity.
2. How does South Africa's patent law impact pharmaceutical patents?
South Africa grants patents for new, inventive, and industrially applicable pharmaceuticals, with protections lasting 20 years from the filing date.
3. Can patent overlaps lead to litigation?
Yes. Overlaps with existing patents can result in invalidity claims or licensing negotiations, especially in active technology areas.
4. Are there specific challenges to patenting drugs in South Africa?
Challenges include demonstrating inventive step and providing sufficient data, particularly because local patent law emphasizes practical utility.
5. How can patent landscape analysis inform R&D investments?
It helps identify existing protections, potential patent conflicts, and gaps, guiding strategic innovation and licensing decisions.
References
[1] South African Patent Office. (2023). Patent register and legal status. Retrieved from https://patentoffice.co.za
[2] World Intellectual Property Organization (WIPO). (2020). Patent Report: South Africa. https://wipo.int/ipstats/en/
